Hester Pharmaceuticals Limited operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hester Pharmaceuticals Limited with three other
pharmaceutical manufacturers in Asia:
sales of 2.96 billion Japanese Yen [US$26.87 million]
Panacea Biotec Ltd
(4.51 billion Indian Rupees [US$63.57 million]
of which 80%
was Formulation), and
Pharma Foods International Co.Ltd
based in Japan
(10.53 billion Japanese Yen [US$95.74 million]
of which 81%
was Functional product(Online business)).
During the year ended March of 2019, sales at
Hester Pharmaceuticals Limited were 1.78 billion Indian Rupees (US$25.13 million).
increase of 31.0%
versus 2018, when the company's sales were 1.36 billion Indian Rupees.
This was the fifth consecutive year of sales increases at Hester Pharmaceuticals Limited
(and since 2014, sales have increased a total of 158%).
Sales of Others saw an increase
that was more than double the company's growth rate: sales were up
2,125.7% in 2019, from
2.28 million Indian Rupees to 50.82 million Indian Rupees.
Hester Pharmaceuticals Limited also saw significant increases in sales in
Large Animal Health Production (up 127.0% to 426.45 million Indian Rupees)